4596 — Kubota Pharmaceutical Holdings Share News
0.000.00%
Table: Kubota Pharmaceutical Holdings -Q1 group results (IFRS)
Table: Kubota Pharmaceutical Holdings -2019 group results (IFRS)
Table: Kubota Pharmaceutical Holdings -2019 parent results
Table: Kubota Pharmaceutical Holdings -9-MTH group results (IFRS)
Table: Kubota Pharmaceutical Holdings -6-MTH group results (IFRS)
Table: Kubota Pharmaceutical Holdings -Q1 group results (IFRS)
Table: Kubota Pharmaceutical Holdings -2018 parent results
Table: Kubota Pharmaceutical Holdings -2018 group results (IFRS)
Table: Kubota Pharmaceutical Holdings -9-MTH group results (IFRS)
Brief: Kubota Pharmaceutical Holdings says exercise of options
Table: Kubota Pharmaceutical Holdings -6-MTH group results (IFRS)
Brief: Kubota Pharmaceutical Holdings says exercise of options
Table: Kubota Pharmaceutical Holdings -Q1 group results (IFRS)
Table: Kubota Pharmaceutical Holdings -2017 parent results
Table: Kubota Pharmaceutical Holdings -2017 group results (IFRS)
Brief: Kubota Pharmaceutical Holdings unit and SIRION Biotech set sights on gene delivery tools for ocular gene therapy
Table: Kubota Pharmaceutical Holdings -9-MTH group results (IFRS)
Brief: Kubota Pharmaceutical Holdings says unit Acucela receives patent covering method of use for emixustat hydrochloride
Table: Kubota Pharmaceutical Holdings -6-MTH group results (IFRS)